Study links higher expression of the gene PROX1 to aggressive change in prostate tumor cells; FDA-approved class of drugs can disable PROX1 ANN ARBOR, Michigan — Researchers at the University of ...

Plasticity in cancer cells describes their inherent ability to undergo alterations and turn certain features on and off at different times. This flexibility sometimes occurs as a result of epigenetic ...

Real world data of precision medicine in the management of metastatic prostate cancer: A retrospective cohort study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

Researchers from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have made a significant advancement that could reshape the treatment landscape ...

DURHAM, N.C. – A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this ...

The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on ...

A new study by Duke researchers marked a major shift in understanding one of the deadliest forms of lung cancer. On Wednesday, researchers released a new study that found small cell lung cancer (SCLC) ...

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...

Prostate cancer remains a global health challenge, ranking as the second most common malignancy among men. While early-stage disease can be effectively managed, advanced forms-particularly metastatic ...